Neurotological and Auditory Brain Stem Response Findings in Human Immunodeficiency Virus—Positive Patients without Neurologic Manifestations

Abstract

Neurologic manifestations of human immunodeficiency virus (HIV) infection, rather than being a late complication of the disease, are principally correlated with the early central nervous system (CNS) localization of HIV. The CNS may be infected in the early stages of acquired immunodeficiency syndrome (AIDS) without evidence of neurologic disorders. Evoked potentials (visual, auditory, and somatosensory) and electronystagmographic test batteries have proven to be very sensitive in showing subclinical CNS disorders due to HIV. In this study, auditory brain stem response (ABR) and electronystagmographic test battery findings (smooth pursuit, saccades, caloric test) were performed in 29 neurologically asymptomatic, HIV-positive subjects at different stages of the disease. Compared to results of a control group, the ABR latencies of waves V, I, and III and interpeaks I-V and III-V were significantly increased in HIV patients. The same parameters did not differ significantly among the stages of the disease. In HIV-positive subjects, the accuracy of saccades was significantly reduced, while latency was normal. The velocity and the gain of pursuit were significantly reduced in HIV-positive patients, and 15 of 29 patients showed corrective saccades. Caloric tests revealed qualitative nystagmus abnormalities in 82% of HIV patients, while quantitative parameters were normal. The present results confirm that CNS involvement by HIV occurs early in the course of the disease. In particular, HIV does not seem to affect the labyrinth or the eighth cranial nerve, as demonstrated by the normality of the I-III value of the ABR and of the quantitative parameters of the caloric responses, but it does appear to involve the brain stem acoustic pathways, pontocerebellar pathways, and supratentorial areas.

Keywords

auditory brain stem response caloric tests human immunodeficiency virus pursuit saccades

Get full access to this article

View all access options for this article.

References

Koralnik

Beaumanoir

Hausler

. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection. N Engl J Med 1990;323: 864–70.

Hollander

Levy

. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med 1987;106: 692–5.

Levy

Bredesen

Rosenblum

. Neurological manifestation of the acquired immunodeficiency syndrome (AIDS) experience at UCSF and review of the literature. Neurosurgery 1985;62: 475–95.

Zandrini

Bollani

Nappi

. Abnormalities of neurophysiological studies in AIDS. Significance and prognostic value. Int Conf AIDS 1992;8: 19–24.

Burquier

Burkhard

Vibert

. Prognostic value of EEG and auditory evoked potentials (AEP) in HIV infection. Int Conf AIDS 1992;8: 8–12.

Rota

Schooley

Jordan

Price

. Isolation of HTLV III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313: 1493–7.

Carlin

. Neuropsychological consequences of drug abuse. In: Grant

Adams

, eds. Neuropsychological assessment of neuropsychiatric disorders. New York, NY: Oxford University Press, 1986: 478–97.

McArthur

Kumar

Johnson

Choen

Seines

. Incidental white matter hyperintensities on magnetic resonance in HIV-1 infection. J Acquir Immune Defic Syndr 1990;3: 252–9.

Cahan

Pagano

Perez

Garau

Casiro

Mangone

. Abnormal brain-stem auditory evoked potentials (BAEPs) in HIV infected individuals. Int Conf AIDS 1990;6: 178–82.

10.

Egan

Chiswick

Goodwin

St Clair

Brettle

. Correlation of P300 auditory evoked potentials (AEPs) and tests of cognitive function in HIV positive drug users. Int Conf AIDS 1989;5: 390–4.

11.

Goodwin

Chiswick

Egan

St Clair

Brettle

. The Edinburgh cohort of HIV-positive drug users. Auditory event-related potentials show progressive slowing in patients with Centers for Disease Control stage IV disease. AIDS 1990;4: 1243–50.

12.

Harman

. Neuropsychological toxicology. New York, NY: Pergamon Press, 1988.

13.

Malessa

Agelink

Brockmeyer

Hengge

Baumann

Weiller

. 3-Year follow up of brain-stem auditory evoked potentials in HIV-patients treated and untreated with zidovudine. Int Conf AIDS 1992;8: 19–24.

14.

Miller

Seines

McArthur

Cohen

Farzedegan

. Neuropsychological performance in HIV-1 infected homosexual men. The Multicenter AIDS Cohort Study (MACS). Neurology 1990;40: 197–203.

15.

McArthur

Cohen

Farzedegan

Seines

Miller

. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988;23(Suppl):S34–S37.

16.

Rosenhall

Hakansson

Lowhagen

Hanner

Jonsson-Ehk

. Neurotological abnormalities in asymptomatic HIV-seropositive patients. Acta Neurol Scand 1989;79: 140–5.

17.

Hart

Cokely

Schupbach

. Neurotological findings of a patient with acquired immunodeficiency syndrome. Ear Hear 1989;10: 68–76.

18.

Harter

. Neuropsychological status of asymptomatic individuals seropositive to HIV-1. Ann Neurol 1989;26: 589–91.

19.

Koralnik

Beaumanoir

Hausler

Kholer

Delacroux

Hirschel

. Abnormalities of EEG and neurotological tests in asymptomatic HIV infected homosexuals. A prospective controlled study. Int Conf AIDS 1989;5: 462–5.

20.

Lalwani

Sooy

. Otologic and neurotological manifestations of the acquired immunodeficiency syndrome. Otolaryngol Clin North Am 1992;25: 1183–97.

21.

Real

Thomas

Gerwin

. Sudden hearing loss and acquired immunodeficiency syndrome. Otolaryngol Head Neck Surg 1987;97: 409–12.

22.

Malessa

Rose

Brockmeyer

Mertins

Schwendemann

. Development of early subclinical alterations in peripheral and central auditory pathways in HIV-infection. An electrophysiological follow up study. Int Conf AIDS 1991;7: 199–201.

23.

Pagano

Cahan

Garau

. Brain-stem auditory evoked potentials in human immunodeficiency virus—seropositive patients with and without acquired immunodeficiency syndrome. Arch Neurol 1992;49: 166–9.